Neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer

STS Webinar: The Evolving Role of Radiation Therapy in Resectable Lung CancerПодробнее

Adherence to adjuvant immunotherapy and TKIs in resected in NSCLCПодробнее

Outcomes and pCR after chemo-immunotherapy in resectable NSCLCПодробнее

SQUAT: neoadjuvant chemo-immuno-radiation and surgery in NSCLCПодробнее

Predicting Response to Neoadjuvant and Perioperative ChemoimmunotherapyПодробнее

When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better ApproachПодробнее

FDA Approves Durvalumab / Imfinzi for Resectable NSCLC Non-Small Cell Lung CancerПодробнее

Adherence & outcomes of neoadjuvant immunotherapy in resectable NSCLCПодробнее

The future of chemo-immunotherapy in resectable non-small cell lung cancerПодробнее

CRSF | Dr. Madala Ravikrishna: Neoadjuvant & Adjuvant Immunotherapy in Early Stage Lung CancerПодробнее

Clinical Investigator Perspectives in Immunotherapy and Other Nontargeted Approaches for Lung CancerПодробнее

Trial updates in neoadjuvant adjuvant therapies for early-stage NSCLCПодробнее

How to Treat Early Stage Non-Small Cell Lung CancerПодробнее

Neoadjuvant Nivolumab + Chemotherapy in Resectable NSCLC | Dr. Pradip Kumar Mondal | CRSF 2023Подробнее

Perioperative Immunotherapy for Resectable NSCLC: Evaluating Approved and Emerging ApproachesПодробнее

Neoadjuvant Immunotherapy for Resectable NSCLC: Dr. Satvik Khaddar on NEOpredict-Lung Phase II StudyПодробнее

July 25, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)Подробнее

Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLCПодробнее

03_07 (Neo)Adjuvant NSCLCПодробнее

ASCO24 Updates: Survival Outcomes: Neoadjuvant vs. Adjuvant Therapy in NSCLCПодробнее